Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Clinical Research
  • Published:

MDT perspective: intraductal carcinoma of the prostate: implication for diagnosis and treatment

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Zhao J, Xu N, Zhu S, Nie L, Zhang M, Zheng L, et al. Genomic and evolutionary characterization of concurrent intraductal carcinoma and adenocarcinoma of the prostate. Cancer Res. 2024;84:154–67.

    Article  PubMed  Google Scholar 

  2. Li J, Xu C, Lee HJ, Ren S, Zi X, Zhang Z, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580:93–99.

    Article  ADS  CAS  PubMed  Google Scholar 

  3. Lozano R, Salles DC, Sandhu S, Aragón IM, Thorne H, López-Campos F, et al. Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer. Eur J Cancer. 2021;147:74–83.

    Article  CAS  PubMed  Google Scholar 

  4. Wang X, Zhou L, Qi L, Zhang Y, Yin H, Gan Y et al. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate Cancer Prostatic Dis. 2023; Online ahead of print.

  5. Russo GI, Soeterik T, Puche-Sanz I, Broggi G, Lo Giudice A, De Nunzio C, et al. Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023;26:646–54.

    Article  PubMed  Google Scholar 

  6. Smith SC, Gandhi JS, Moch H, Aron M, Compérat E, Paner GP, et al. Similarities and differences in the 2019 ISUP and GUPS recommendations on prostate cancer grading: a guide for practicing pathologists. Adv Anat Pathol. 2021;28:1–7.

    Article  PubMed  Google Scholar 

  7. Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, et al. Intraductal carcinoma of the prostate: pathogenesis and molecular perspectives. Eur Urol Focus. 2021;7:955–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

YZ, HZ, SZ, JL, and NC both contributed to the drafting and final approval of this manuscript.

Corresponding author

Correspondence to Yao Zhu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, H., Zhu, S., Li, J. et al. MDT perspective: intraductal carcinoma of the prostate: implication for diagnosis and treatment. Prostate Cancer Prostatic Dis (2024). https://doi.org/10.1038/s41391-024-00818-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41391-024-00818-y

Search

Quick links